Completed from United Kingdom
What a brilliant course! The Certificado En Economía De La Salud Farmacéutica (Advanced) gave me exactly the expertise I needed to transition into health‑technology assessment. The modules on HTA frameworks and value‑based pricing were packed with real‑world examples, and the interactive webinars let us discuss recent NHS reforms directly with the tutors. I walked away with a ready‑to‑use toolkit for conducting budget impact analyses, which I’ve already applied to a new vaccine rollout project. The resources were top‑notch, and the overall experience was energising and highly relevant to today’s pharmaceutical landscape.
The Certificado En Economía De La Salud Farmacéutica (Advanced) at Stanmore School of Business exceeded my expectations. The curriculum was directly aligned with my goal of mastering health‑economics models for pharmaceutical pricing. I especially valued the deep dive into cost‑effectiveness analysis using real‑world data sets; the hands‑on Excel and R modules allowed me to produce a full budget impact model for a new oncology drug, which I later presented to my employer. The lecture videos were clear, and the supplemental readings were up‑to‑date with current EU and US regulatory guidelines. Overall, the course was professionally delivered, and I feel fully equipped to contribute strategically to my company's pricing team.
I took the advanced health‑economics certificate because I wanted to get a better grip on pharmaceutical market access. The course was super practical – the case studies from Latin America and the UK helped me see how pricing negotiations differ across regions. I learned how to build a simple Markov model for a chronic disease therapy, which I’ve already used in my current role at a biotech start‑up. The material was well‑organized, and the instructors were quick to answer questions on the forum. It was a relaxed but solid learning experience, and I’d definitely recommend it to anyone looking to boost their skill set.
The advanced certificate was extremely detailed and covered every facet I was looking for – from pharmacoeconomic theory to practical implementation in emerging markets. I particularly appreciated the module on pricing strategies in low‑ and middle‑income countries, which included a step‑by‑step guide to performing a willingness‑to‑pay analysis. The course material, including the downloadable datasets and template models, was of high quality and easy to follow. My final project involved creating a cost‑utility analysis for a diabetes medication, and I received valuable feedback that sharpened my analytical approach. Overall, a thorough and rewarding learning journey.
